Veru Inc.
VERU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000863894
In the last 90 days, Veru Inc. insiders filed 1 open-market purchase and 0 sales; 61 institutions reported holding it in 13F filings for Q2 2026, worth $9.45M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Veru Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 131
- +8 vs. Q4 2024
- Shares held
- 47.5M
- −9.50M (−16.7%) vs. Q4 2024
- Total value
- $23.3M
- −$13.8M (−37.2%) vs. Q4 2024
- New holders
- 19
- 47 more added
- Sold out
- 11
- 30 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VERU on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 61 | $9.45M |
| Q1 2026 | 59 | $7.77M |
| Q4 2025 | 53 | $7.63M |
| Q3 2025 | 65 | $12.6M |
| Q2 2025 | 126 | $21.7M |
| Q1 2025 | 131 | $23.3M |
| Q4 2024 | 124 | $37.2M |
| Q3 2024 | 113 | $46.2M |
| Q2 2024 | 107 | $51.2M |
| Q1 2024 | 94 | $33.5M |
| Q4 2023 | 90 | $43.1M |
| Q3 2023 | 63 | $9.34M |
| Q2 2023 | 84 | $18.9M |
| Q1 2023 | 108 | $37.3M |
| Q4 2022 | 131 | $246.2M |
| Q3 2022 | 142 | $454.0M |
| Q2 2022 | 131 | $509.5M |
| Q1 2022 | 98 | $110.3M |
| Q4 2021 | 111 | $137.3M |
| Q3 2021 | 110 | $208.4M |
| Q2 2021 | 111 | $196.8M |
| Q1 2021 | 110 | $286.0M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Veru Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Independent Financial Group, LLC | 154,000 | $75.5K | 0.00% | −11,500−6.9% | Reduced |
| Barclays PLC | 172,245 | $84.4K | 0.00% | −34,270−16.6% | Reduced |
| Bank of America Corp | 176,032 | $86.3K | 0.00% | −41,760−19.2% | Reduced |
| Nuveen, LLC | 178,557 | $87.5K | 0.00% | +178,557 | New |
| Citadel Advisors LLC | 232,174 | $113.8K | 0.00% | −180,647−43.8% | Reduced |
| Advisor Group Holdings, Inc. | 234,866 | $115.1K | 0.00% | +170,819+266.7% | Added |
| Atria Investments LLC | 253,256 | $124.1K | 0.00% | +81,549+47.5% | Added |
| Price T Rowe Associates Inc | 253,180 | $125.0K | 0.00% | +147,071+138.6% | Added |
| Goldman Sachs Group Inc | 289,098 | $141.7K | 0.00% | −41,504−12.6% | Reduced |
| Blair William & Co | 350,000 | $171.5K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 375,291 | $183.9K | 0.00% | +65,045+21.0% | Added |
| Morgan Stanley | 376,367 | $184.5K | 0.00% | −1,087,732−74.3% | Reduced |
| Bank of New York Mellon Corp | 377,043 | $184.8K | 0.00% | +61,002+19.3% | Added |
| Boothbay Fund Management, LLC | 405,292 | $198.6K | 0.01% | +142,368+54.1% | Added |
| 180 Wealth Advisors, LLC | 433,333 | $212.4K | 0.03% | +139,983+47.7% | Added |
| Susquehanna International Group, LLP | 521,058 | $255.4K | 0.00% | +192,375+58.5% | Added |
| Envestnet Asset Management Inc | 666,294 | $326.6K | 0.00% | +259,539+63.8% | Added |
| RSM US Wealth Management LLC | 669,277 | $328.0K | 0.01% | +269,500+67.4% | Added |
| Adage Capital Partners GP, L.L.C. | 1,000,000 | $490.1K | 0.00% | −1,300,000−56.5% | Reduced |
| Northern Trust Corp | 1,047,756 | $513.5K | 0.00% | +18,582+1.8% | Added |
| Deutsche Bank AG | 1,101,786 | $539.9K | 0.00% | +4900.0% | Added |
| Oppenheimer & Co Inc | 1,325,246 | $649.5K | 0.01% | +204,660+18.3% | Added |
| Cambridge Investment Research Advisors, Inc. | 1,423,288 | $698.0K | 0.00% | +206,614+17.0% | Added |
| Ikarian Capital, LLC | 1,425,239 | $698.5K | 0.23% | +480,000+50.8% | Added |
| PVG Asset Management Corp | 1,596,900 | $782.6K | 3.41% | +549,590+52.5% | Added |
| UBS Group AG | 1,966,781 | $963.7K | 0.00% | +1,518,216+338.5% | Added |
| State Street Corp | 2,234,038 | $1.09M | 0.00% | −44,993−2.0% | Reduced |
| Geode Capital Management, LLC | 3,033,107 | $1.49M | 0.00% | +35,356+1.2% | Added |
| Vanguard Group Inc | 6,251,075 | $3.06M | 0.00% | +31,289+0.5% | Added |
| MPM Oncology Impact Management LP | 6,592,727 | $3.23M | 0.56% | +2,307,362+53.8% | Added |
| BlackRock, Inc. | 8,648,555 | $4.24M | 0.00% | +337,553+4.1% | Added |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −6,483,157−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −2,028,534−100.0% | Sold out |
| Exome Asset Management LLC | 0 | $0 | 0.00% | −1,117,600−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −331,800−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −52,669−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −50,722−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −33,646−100.0% | Sold out |
| Keystone Financial Group | 0 | $0 | 0.00% | −32,000−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −20,889−100.0% | Sold out |
| Sound Income Strategies, LLC | 0 | $0 | 0.00% | −3,676−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −950−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |